AADI BIOSCIENCE, INC.

Analyst Reco. Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
2.02 ^USD	+4.12%		+20.24%	0.00%

13/03	Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
13/03	Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating	15/12	MT
HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy	15/12	MT
HC Wainwright Adjusts Price Target on Aadi Bioscience to $45 From $48, Maintains Buy Rating	29/23/29	MT
HC Wainwright Adjusts Aadi Bioscience's Price Target to $48 from $49, Keeps Buy Rating	11/22/11	MT
Jefferies Starts Aadi Bioscience at Buy With $45 Price Target	11/22/11	MT
HC Wainwright Adjusts Aadi Bioscience's Price Target to $49 From $47, Keeps Buy Rating	24/21/24	MT
AADI BIOSCIENCE : Cowen Starts Aadi Bioscience at Outperform	01/21/01	MT
AADI BIOSCIENCE : Ladenburg Thalmann Initiates Coverage on Aadi Bioscience With Buy Rating, $51 Price Target	14/21/14	MT
AADI BIOSCIENCE : Piper Sandler Starts Aadi Bioscience at Overweight With $45 Price Target	08/21/08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer